Roberta Filograna
Roberta Filograna
Postdoctaral fellowship, Karolinska Institutet
Verified email at ki.se
Title
Cited by
Cited by
Year
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
I Russo, G Berti, N Plotegher, G Bernardo, R Filograna, L Bubacco, ...
Journal of neuroinflammation 12 (1), 1-13, 2015
572015
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
M Bisaglia, R Filograna, M Beltramini, L Bubacco
Ageing research reviews 13, 107-114, 2014
552014
The clinical use of the neutrophil to lymphocyte ratio (NLR) in urothelial cancer: a systematic review
M Marchioni, G Primiceri, M Ingrosso, R Filograna, P Castellan, ...
Clinical genitourinary cancer 14 (6), 473-484, 2016
532016
A phenotype-driven approach to generate mouse models with pathogenic mtDNA mutations causing mitochondrial disease
JHK Kauppila, HL Baines, A Bratic, ML Simard, C Freyer, A Mourier, ...
Cell reports 16 (11), 2980-2990, 2016
502016
Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE (2)-M17 neuroblastoma cell lines upon differentiation
R Filograna, L Civiero, V Ferrari, G Codolo, E Greggio, L Bubacco, ...
PloS one 10 (8), e0136769, 2015
402015
Superoxide dismutase (SOD)-mimetic M40403 is protective in cell and fly models of paraquat toxicity implications for parkinson disease
R Filograna, VK Godena, A Sanchez-Martinez, E Ferrari, L Casella, ...
Journal of Biological Chemistry 291 (17), 9257-9267, 2016
372016
Anti-oxidants in Parkinson’s disease therapy: a critical point of view
R Filograna, M Beltramini, L Bubacco, M Bisaglia
Current neuropharmacology 14 (3), 260-271, 2016
352016
Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse
R Filograna, C Koolmeister, M Upadhyay, A Pajak, P Clemente, R Wibom, ...
Science advances 5 (4), eaav9824, 2019
122019
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
A Biosa, A Sanchez-Martinez, R Filograna, A Terriente-Felix, SM Alam, ...
Human molecular genetics 27 (9), 1618-1629, 2018
102018
Defects of mitochondrial RNA turnover lead to the accumulation of double-stranded RNA in vivo
A Pajak, I Laine, P Clemente, N El-Fissi, FA Schober, C Maffezzini, ...
PLoS genetics 15 (7), e1008240, 2019
42019
Erratum to: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
I Russo, G Berti, N Plotegher, G Bernardo, R Filograna, L Bubacco, ...
Journal of Neuroinflammation 13 (1), 1-1, 2016
12016
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells
A Biosa, F De Lazzari, A Masato, R Filograna, N Plotegher, M Beltramini, ...
Neurotoxicity research 36 (4), 746-755, 2019
2019
Defects of mitochondrial RNA turnover lead to the accumulation of double-stranded RNA in vivo
I Laine, N El-Fissi, J Calvo-Garrido, R Filograna, A Dhir, A Wedell
2019
NOVEL USE OF A SUPEROXIDE RADICAL DISMUTATING AGENTS AS A THERAPEUTIC APPROACH TO HAMPER THE PROGRESSION OF PARKINSON’S DISEASE
R Filograna, VK Godena, A Sanchez-Martinez, L Bubacco, M Beltramini, ...
Journal of International Society of Antioxidants in Nutrition & Health 1 (1), 2016
2016
Kauppila JHK, Baines HL, Bratic A, Simard ML, Freyer C, Mourier A, Stamp C
R Filograna, NG Larsson, LC Greaves, JB Stewart
2016
Superoxide radical dismutation as protective mechanism to hamper the progression of Parkinson's disease
R Filograna
Universitą di Padova, 2015
2015
465 Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis Fausto Petrelli, Andrea Coinu, Ivano …
M Marchioni, G Primiceri, M Ingrosso, R Filograna, P Castellan, ...
The system can't perform the operation now. Try again later.
Articles 1–17